Lead EvaluAtion for Defibrillation and Reliability (LEADR) / Lead Evaluation for Defibrillation and Reliability in Left Bundle Branch Area Pacing (LEADR LBBAP)

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1007 participants.

Also called NCT04863664

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 1,007 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT04863664
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Australia, Austria, Belgium, Canada, China, Denmark, France, Germany, Hong Kong SAR China, Italy, Japan, Malaysia, Netherlands, Poland, Portugal, Serbia, Singapore, Spain, United Kingdom (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT04863664. Non-randomized; no masking; primary purpose treatment. Start 2021-06-21 (actual); primary completion 2025-09-03 (actual). Results posted on 2026-11-04.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Lead EvaluAtion for Defibrillation and Reliability (LEADR) / Lead Evaluation for Defibrillation and Reliability in Left Bundle Branch Area Pacing (LEADR LBBAP)
Condition
Ventricular Tachyarrhythmia
Intervention (Device)
Defibrillation (RV Implant)
Intervention (Device)
Defibrillation (LBBAP Implant)
Lead sponsor
Medtronic Cardiac Rhythm and Heart Failure (class: industry)

Record details

Record id
cardio:ct-nct04863664
Content hash
d19e7a5debe79e85301e7f5d0be5aa780192d5338007c65053f97fa6b52bdb4a